AP309A - Novel pyrrolopyridines, pharmaceutical compositions containing them and their preparations. - Google Patents

Novel pyrrolopyridines, pharmaceutical compositions containing them and their preparations. Download PDF

Info

Publication number
AP309A
AP309A APAP/P/1992/000369A AP9200369A AP309A AP 309 A AP309 A AP 309A AP 9200369 A AP9200369 A AP 9200369A AP 309 A AP309 A AP 309A
Authority
AP
ARIPO
Prior art keywords
compound
formula
alkyl
pharmaceutically acceptable
pyridine
Prior art date
Application number
APAP/P/1992/000369A
Other languages
English (en)
Other versions
AP9200369A0 (en
Inventor
Carin Brivin
Marie Elebring
Stig Carlsson
Robert Carter
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Astra filed Critical Ab Astra
Publication of AP9200369A0 publication Critical patent/AP9200369A0/xx
Application granted granted Critical
Publication of AP309A publication Critical patent/AP309A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
APAP/P/1992/000369A 1991-03-27 1992-03-23 Novel pyrrolopyridines, pharmaceutical compositions containing them and their preparations. AP309A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9100920A SE9100920D0 (sv) 1991-03-27 1991-03-27 New active compounds

Publications (2)

Publication Number Publication Date
AP9200369A0 AP9200369A0 (en) 1992-04-30
AP309A true AP309A (en) 1994-01-13

Family

ID=20382295

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1992/000369A AP309A (en) 1991-03-27 1992-03-23 Novel pyrrolopyridines, pharmaceutical compositions containing them and their preparations.

Country Status (30)

Country Link
US (1) US5439917A (de)
EP (2) EP0509974B1 (de)
JP (1) JP3122792B2 (de)
CN (1) CN1067892A (de)
AP (1) AP309A (de)
AT (1) ATE175672T1 (de)
AU (1) AU655634B2 (de)
BG (1) BG98124A (de)
CA (1) CA2106880A1 (de)
DE (1) DE69228142T2 (de)
DK (1) DK0509974T3 (de)
ES (1) ES2129039T3 (de)
FI (1) FI934203A7 (de)
GR (1) GR3029834T3 (de)
HU (1) HUT65948A (de)
IE (1) IE920915A1 (de)
IL (1) IL101347A0 (de)
IS (1) IS3827A (de)
JO (1) JO1704B1 (de)
MA (1) MA22477A1 (de)
MX (1) MX9201324A (de)
NO (1) NO933425L (de)
NZ (1) NZ241943A (de)
SE (1) SE9100920D0 (de)
SK (1) SK103093A3 (de)
TN (1) TNSN92026A1 (de)
TW (1) TW198032B (de)
WO (1) WO1992017477A1 (de)
YU (1) YU30292A (de)
ZA (1) ZA921823B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100920D0 (sv) * 1991-03-27 1991-03-27 Astra Ab New active compounds
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
EP1990343B1 (de) * 1999-12-24 2012-04-04 Aventis Pharma Limited Azaindole
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
GB0115109D0 (en) 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
KR20040111445A (ko) * 2002-03-28 2004-12-31 에자이 가부시키가이샤 신경퇴행성 질환 치료용 ｃ─Ｊｕｎ Ｎ─말단 키나아제억제제로서의 ７─아자인돌
AU2003254282A1 (en) * 2002-08-01 2004-02-23 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
GB0305142D0 (en) 2003-03-06 2003-04-09 Eisai London Res Lab Ltd Synthesis
DK1606261T3 (da) 2003-03-10 2010-01-18 Nycomed Gmbh Hidtil ukendt fremgangsmåde til fremstilling af roflumilast
US6981980B2 (en) 2003-03-19 2006-01-03 Phagia Technology Self-inflating intragastric volume-occupying device
WO2004101565A2 (en) * 2003-05-16 2004-11-25 Eisai Co., Ltd. Jnk inhibitors
GB0405055D0 (en) * 2004-03-05 2004-04-07 Eisai London Res Lab Ltd JNK inhibitors
AU2006224619B2 (en) * 2005-03-16 2012-06-07 Takeda Gmbh Taste masked dosage form containing roflumilast
GB0516156D0 (en) * 2005-08-05 2005-09-14 Eisai London Res Lab Ltd JNK inhibitors
CL2007002617A1 (es) 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
AU2007317561A1 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
CN101980700A (zh) 2008-02-20 2011-02-23 密苏里大学董事会 包含奥美拉唑和兰索拉唑以及缓冲剂的组合的组合物及其使用方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0509974A1 (de) * 1991-03-27 1992-10-21 Astra Aktiebolag Pyrolo[2,3-b]pyridine mit therapeutischer Wirkung und Verfahren zu deren Herstellung

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0509974A1 (de) * 1991-03-27 1992-10-21 Astra Aktiebolag Pyrolo[2,3-b]pyridine mit therapeutischer Wirkung und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
EP0580616A1 (de) 1994-02-02
IE920915A1 (en) 1992-10-07
IS3827A (is) 1992-09-28
AU655634B2 (en) 1995-01-05
AU1426092A (en) 1992-11-02
BG98124A (bg) 1994-11-15
NZ241943A (en) 1993-12-23
MA22477A1 (fr) 1992-10-01
DE69228142D1 (de) 1999-02-25
ATE175672T1 (de) 1999-01-15
TNSN92026A1 (fr) 1993-06-08
FI934203A0 (fi) 1993-09-24
IL101347A0 (en) 1992-11-15
DK0509974T3 (da) 1999-08-30
SE9100920D0 (sv) 1991-03-27
JO1704B1 (en) 1992-12-15
NO933425D0 (no) 1993-09-24
US5439917A (en) 1995-08-08
CN1067892A (zh) 1993-01-13
ZA921823B (en) 1992-11-25
EP0509974A1 (de) 1992-10-21
FI934203L (fi) 1993-09-24
JP3122792B2 (ja) 2001-01-09
EP0509974B1 (de) 1999-01-13
DE69228142T2 (de) 1999-07-22
JPH06506448A (ja) 1994-07-21
YU30292A (sh) 1995-01-31
CA2106880A1 (en) 1992-09-28
AP9200369A0 (en) 1992-04-30
MX9201324A (es) 1992-10-01
TW198032B (de) 1993-01-11
SK103093A3 (en) 1994-08-10
HU9302741D0 (en) 1993-12-28
WO1992017477A1 (en) 1992-10-15
ES2129039T3 (es) 1999-06-01
FI934203A7 (fi) 1993-09-24
GR3029834T3 (en) 1999-06-30
HUT65948A (en) 1994-08-29
NO933425L (no) 1993-10-25

Similar Documents

Publication Publication Date Title
RU2193036C2 (ru) Производные имидазо[1,2-а]пиридина, способы их получения, фармацевтический препарат на их основе, способ ингибирования секреции желудочной кислоты, способ лечения желудочно-кишечных воспалительных заболеваний и способ лечения состояний, в которые вовлечено инфицирование h.pylori
JP3692034B2 (ja) 胃酸分泌を阻害するイミダゾピリジン誘導体
EP0509974B1 (de) Pyrolo[2,3-b]pyridine mit therapeutischer Wirkung und Verfahren zu deren Herstellung
KR100339059B1 (ko) 이미다조[1,2-a]피리딘의알콕시알킬카르바메이트
US6613775B1 (en) Imidazo[1,2-a]pyridine compounds
EP1737862A1 (de) Imidazopyridinverbindung
WO1993008168A1 (fr) Derive de thioformamide
MXPA01001720A (en) New compounds
MXPA00010231A (en) Imidazo pyridine derivatives which inhibit gastric acid secretion
MXPA99007650A (en) Compounds for inhibition of gastric acid secretion
MXPA01001724A (en) New compounds
HK1024248B (en) Compounds for inhibition of gastric acid secretion
HK1036274B (en) Imidazo (1,2-a) pyridine derivatives for the treatment of gastrointestinal diseases
HK1033317B (en) Imidazo pyridine derivatives which inhibit gastric acid secretion